Arizona State Retirement System Supernus Pharmaceuticals, Inc. Transaction History

Arizona State Retirement System

  • $18.2 Billion
  • Q3 2025

A detailed history of Arizona State Retirement System transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 16,547 shares of SUPN stock, worth $744,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,547
Previous 16,270 1.7%
Holding current value
$744,615
Previous $512,000 54.3%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025
BUY
$31.45 - $47.79 $8,711 - $13,237
277 Added 1.7%
16,547 $790,000
Q2 2025

Aug 13, 2025
BUY
$30.29 - $33.43 $13,024 - $14,374
430 Added 2.71%
16,270 $512,000
Q1 2025

May 01, 2025
SELL
$31.17 - $40.0 $4,488 - $5,760
-144 Reduced 0.9%
15,840 $518,000
Q4 2024

Feb 06, 2025
BUY
$31.89 - $37.83 $4,911 - $5,825
154 Added 0.97%
15,984 $577,000
Q3 2024

Nov 12, 2024
BUY
$25.77 - $35.16 $11,957 - $16,314
464 Added 3.02%
15,830 $493,000
Q2 2024

Aug 05, 2024
BUY
$25.99 - $33.85 $8,784 - $11,441
338 Added 2.25%
15,366 $411,000
Q1 2024

May 07, 2024
SELL
$27.11 - $35.17 $6,316 - $8,194
-233 Reduced 1.53%
15,028 $512,000
Q4 2023

Jan 24, 2024
SELL
$22.72 - $29.68 $5,680 - $7,420
-250 Reduced 1.61%
15,261 $441,000
Q3 2023

Nov 06, 2023
BUY
$27.57 - $32.91 $6,561 - $7,832
238 Added 1.56%
15,511 $427,000
Q2 2023

Aug 01, 2023
SELL
$29.91 - $38.73 $11,664 - $15,104
-390 Reduced 2.49%
15,273 $459,000
Q1 2023

Apr 27, 2023
BUY
$34.93 - $42.03 $19,840 - $23,873
568 Added 3.76%
15,663 $567,000
Q4 2022

Feb 07, 2023
BUY
$31.09 - $37.88 $18,032 - $21,970
580 Added 4.0%
15,095 $538,000
Q3 2022

Nov 07, 2022
BUY
$28.79 - $35.41 $2,965 - $3,647
103 Added 0.71%
14,515 $491,000
Q2 2022

Jul 28, 2022
BUY
$25.33 - $34.25 $911 - $1,233
36 Added 0.25%
14,412 $417,000
Q1 2022

May 04, 2022
BUY
$28.51 - $32.9 $2,052 - $2,368
72 Added 0.5%
14,376 $465,000
Q4 2021

Feb 04, 2022
SELL
$26.37 - $34.22 $3,639 - $4,722
-138 Reduced 0.96%
14,304 $417,000
Q3 2021

Nov 12, 2021
BUY
$23.54 - $31.39 $2,848 - $3,798
121 Added 0.84%
14,442 $385,000
Q2 2021

Aug 02, 2021
SELL
$26.72 - $33.19 $27,147 - $33,721
-1,016 Reduced 6.62%
14,321 $441,000
Q1 2021

May 06, 2021
BUY
$24.15 - $31.45 $2,004 - $2,610
83 Added 0.54%
15,337 $402,000
Q4 2020

Jan 28, 2021
SELL
$17.7 - $25.81 $10,602 - $15,460
-599 Reduced 3.78%
15,254 $384,000
Q3 2020

Nov 05, 2020
BUY
$20.2 - $25.05 $81,042 - $100,500
4,012 Added 33.88%
15,853 $330,000
Q2 2020

Aug 04, 2020
SELL
$17.09 - $24.89 $8,117 - $11,822
-475 Reduced 3.86%
11,841 $281,000
Q1 2020

May 05, 2020
SELL
$14.45 - $24.69 $327,552 - $559,672
-22,668 Reduced 64.8%
12,316 $222,000
Q4 2019

Jan 27, 2020
SELL
$19.93 - $29.13 $530,456 - $775,324
-26,616 Reduced 43.21%
34,984 $830,000
Q3 2019

Oct 31, 2019
SELL
$25.47 - $33.37 $500,714 - $656,020
-19,659 Reduced 24.19%
61,600 $1.69 Million
Q2 2019

Jul 25, 2019
BUY
$29.96 - $38.87 $16,418 - $21,300
548 Added 0.68%
81,259 $2.69 Million
Q1 2019

Apr 29, 2019
BUY
$32.77 - $41.99 $7,733 - $9,909
236 Added 0.29%
80,711 $2.83 Million
Q4 2018

Jan 28, 2019
BUY
$30.84 - $49.51 $145,934 - $234,281
4,732 Added 6.25%
80,475 $2.67 Million
Q3 2018

Oct 29, 2018
BUY
$42.7 - $56.55 $15,969 - $21,149
374 Added 0.5%
75,743 $3.81 Million
Q2 2018

Aug 07, 2018
SELL
$44.1 - $59.85 $259,837 - $352,636
-5,892 Reduced 7.25%
75,369 $4.51 Million
Q1 2018

May 14, 2018
SELL
$37.15 - $46.9 $182,035 - $229,810
-4,900 Reduced 5.69%
81,261 $3.72 Million
Q4 2017

Feb 09, 2018
BUY
$36.4 - $42.6 $2.18 Million - $2.55 Million
59,860 Added 227.6%
86,161 $3.43 Million
Q3 2017

Nov 14, 2017
BUY
$36.75 - $49.65 $966,561 - $1.31 Million
26,301
26,301 $1.05 Million

Others Institutions Holding SUPN

# of Institutions
330
Shares Held
60.2M
Call Options Held
234K
Put Options Held
0
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.41B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email